Détail de l'auteur
Documents disponibles écrits par cet auteur (15)
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)
Scalco RS, Lucia A, Santalla A, et al.
Orphanet journal of rare diseases, 2020, 15, 1, p 330
Rare slow channel congenital myasthenic syndromes without repetitive compound muscle action potential and dramatic response to low dose fluoxetine
Durmus H, Sticht H, Ceylaner S, et al.
Acta neurologica Belgica, 2020
Expanding the disease phenotype of ADSSL1-associated myopathy in non-Korean patients
Mroczek M, Durmus H, Bijarnia-Mahay S, et al.
Neuromuscular disorders : NMD, 2020
Cognition of the mothers of patients with Duchenne muscular dystrophy
Demirci H, Durmus H, Toksoy G, et al.
Muscle & Nerve, 2020
Late-onset generalized myasthenia gravis: clinical features, treatment, and outcome
Yildiz Celik S, Durmus H, Yilmaz V, et al.
Acta neurologica Belgica, 2019
A novel homozygous FBXO38 variant causes an early-onset distal hereditary motor neuronopathy type IID
Akcimen F, Vural A, Durmus H, et al.
Journal of human genetics, 2019
Extending the clinical and mutational spectrum of TRIM32-related myopathies in a non-Hutterite population
Johnson K, De Ridder W, Töpf A, et al.
Journal of neurology, neurosurgery, and psychiatry, 2018
A database for screening and registering late onset Pompe disease in Turkey
Gokyigit MC, Ekmekci H, Durmus H, et al.
Neuromuscular disorders : NMD, 2018, 28, 3, p 262
Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up
Durmus H, Shen XM, Serdaroglu-Oflazer P, et al.
Neuromuscular disorders : NMD, 2017
Titin antibodies in "seronegative" myasthenia gravis - A new role for an old antigen
Stergiou C, Lazaridis K, Zouvelou V, et al.
Journal of neuroimmunology, 2016, 292, p 108
Neuromuscular endplate pathology in recessive desminopathies: Lessons from man and mice
Durmus H, Ayhan Ö, Cirak S, et al.
Neurology, 2016, 87, 8, p 799
MuSK autoantibodies in myasthenia gravis detected by cell based assay - A multinational study
Tsonis AI, Zisimopoulou P, Lazaridis K, et al.
Journal of neuroimmunology, 2015, 284, p 10
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis
Zisimopoulou P, Evangelakou P, Tzartos J, et al.
Journal of autoimmunity, 2014, 52, p 139
Oculopharyngodistal myopathy is a distinct entity. Clinical and genetic features of 47 patients
Durmus H, Laval SH, Deymeer F, et al.
Neurology, 2011, 76, 3, p. 227-235
Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations
Schara U, Christen HJ, Durmus H, et al.
European journal of paediatric neurology, 2009, 14, 4, p. 326-333
